Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Stadler

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|March 20, 2003
Acute bilateral abducens paralysis due to oxaliplatinEric Winquist, Mark Vincent, Walter Stadler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Randomized discontinuation design: application to cytostatic antineoplastic agentsGary L Rosner, Walter Stadler, Mark J Ratain
Urology|November 10, 2004
Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysisAshesh B Jani, Mitchell Sokoloff, Arieh Shalhav, et al.
Urologic Oncology|October 7, 2004
9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901Asim Amin, Susan Halabi, Edward P Gelmann, et al.
Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.
World Journal of Radiology|January 10, 2012
Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancerArda Kayhan, Cheng Yang, Fatma Nur Soylu, et al.
Clinical Genitourinary Cancer|February 15, 2008
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study designDeborah A Bradley, Rodney Dunn, David Nanus, et al.
The American Journal of Medicine|December 3, 2002
Thalidomide-associated deep vein thrombosis and pulmonary embolismCharles L Bennett, Glen T Schumock, Apurva A Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Activities and accomplishments of the cancer and leukemia group B genitourinary committeeEric J Small, Susan Halabi, Phillip Kantoff, et al.
Anti-Cancer Drugs|April 28, 2009
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium studyPrimo N Lara, Jeff Longmate, Christopher P Evans, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|March 20, 2003
Acute bilateral abducens paralysis due to oxaliplatinEric Winquist, Mark Vincent, Walter Stadler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Randomized discontinuation design: application to cytostatic antineoplastic agentsGary L Rosner, Walter Stadler, Mark J Ratain
Urology|November 10, 2004
Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysisAshesh B Jani, Mitchell Sokoloff, Arieh Shalhav, et al.
Urologic Oncology|October 7, 2004
9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901Asim Amin, Susan Halabi, Edward P Gelmann, et al.
Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.
World Journal of Radiology|January 10, 2012
Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancerArda Kayhan, Cheng Yang, Fatma Nur Soylu, et al.
Clinical Genitourinary Cancer|February 15, 2008
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study designDeborah A Bradley, Rodney Dunn, David Nanus, et al.
The American Journal of Medicine|December 3, 2002
Thalidomide-associated deep vein thrombosis and pulmonary embolismCharles L Bennett, Glen T Schumock, Apurva A Desai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Activities and accomplishments of the cancer and leukemia group B genitourinary committeeEric J Small, Susan Halabi, Phillip Kantoff, et al.
Anti-Cancer Drugs|April 28, 2009
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium studyPrimo N Lara, Jeff Longmate, Christopher P Evans, et al.
Pageof 4